Sanjay Rai India city Delhi hospital covid-19 vaccine Volunteers Updates Sanjay Rai India city Delhi

India's first COVID-19 vaccine Covaxin: From human trials to test results — key updates

Reading now: 913
www.livemint.com

Here's all you need to know about the human trial of Covaxin:No side-effect so far: A 30-year-old man took the first dose of COVID-19 vaccine candidate at Delhi's All India Institutes of Medical Sciences (AIIMS) last week as part of human trial. "No immediate side-effects have been observed so far," Dr Sanjay Rai, professor at the centre for community medicine at AIIMS said.Covaxin shows "encouraging" results in PGIMS RohtakThe first phase of human trial was completed in PGIMS Rohtak.

The hospital started trial on July 17 and around 50 volunteers enrolled for this exercise. "50 people across India were administered the vaccine and the results were encouraging," Dr Savita Verma, principal investigator of the vaccine trial team, told news.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA